İsmail Sarı

Dr. İsmail Sarı


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2012 in Experimental Diabetes Research
Verified
Journal Article
Open access
PDF file
VÇVeysel Kenan Çelık
Veysel Kenan Çelık
ZŞZeynep Deniz Şahın
Zeynep Deniz Şahın
İSİsmail Sarı
İsmail Sarı
SBSevtap Bakir
Sevtap Bakir
Objective. Oxidative stress is considered to be the main factor in the development of diabetic complications and tissue injury. our objective was to investigate and compare the oxidant/antioxidant conditions and detoxification mechanisms of the liver, lung, kidney, cardiac tissues, and mitochondria of rats with diabetes induced by streptozocin (STZ).Methods. Rats with diabetes induced by streptozocin were anesthetized by administering 90 mg/kg ketamine hydrochloride and 3 mg/kg xylazine hydrochloride. Thoracic cavities were incised open; liver, lung, kidney, and cardiac tissues were removed and stored at−70°C. All samples were homogenized and mitochondrial fractions were separated. Total Antioxidant Status (TAS), Total Oxidant Status (TOS), Oxidative Stress Index (OSI), Paraoxonase (PON), Arylesterase, Catalase (Cat), Malondialdehyde (MDA), and Glutathion-S-transferase were measured in each fraction.Results. MDA and TOS levels were significantly increased in liver tissues, and T OS and OSI were increased in the mitochondrial fractions of diabetic rats. These increases were not statistically significant compared to the control group. No significant differences were determined in the antioxidant and GST activities.Conclusion. According to our results, oxidative stress has not developed in rats with diabetes induced by streptozocin. The detoxification system was induced; however, this induction did not differ significantly from the controls.

1 May 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SASerdal Arslan
Serdal Arslan
AEAynur Engin
Aynur Engin
EAEylem Itir Aydemir
Eylem Itir Aydemir
NSNil Ozbilum Sahin
Nil Ozbilum Sahin
BBBurcu Bayyurt
Burcu Bayyurt
MBMehmet Bakir
Mehmet Bakir

19 July 2013 in Journal of Medical Virology
Verified
Journal Article
Closed access
PDF file
MBMehmet Bakir
Mehmet Bakir
SBSevtap Bakir
Sevtap Bakir
İSİsmail Sarı
İsmail Sarı
VCVeysel Kenan Celik
Veysel Kenan Celik
MGMustafa Gokhan Gozel
Mustafa Gokhan Gozel
AEAynur Engin
Aynur Engin

28 February 2023 in Journal of Molecular Structure
Verified
Journal Article
Closed access
İSİsmail Sarı
İsmail Sarı
SESerpil Erşan
Serpil Erşan
EOEsma Ozmen
Esma Ozmen
DADurmuş Ayan
Durmuş Ayan
EEErdal Erşan
Erdal Erşan
SKSavaş Kaya
Savaş Kaya

15 August 2014 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
MYMeral Yilmaz
Meral Yilmaz
TKTurgut Kacan
Turgut Kacan
İSİsmail Sarı
İsmail Sarı
SKSaadettin Kilickap
Saadettin Kilickap
In this case-control study, we aimed to investigate the relationship between the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and lung cancer. Total 200 individuals including 100 patients with lung cancer and 100 controls were analyzed. Genotyping of MTHFR C677T was performed using PCR and RFLP methods. The majority of the patients were men and 90% were smokers. We found that the risk ratio for development of LC was 13-times higher in smokers compared with non-smokers between patient and control groups in our study (OR:13.5, 95%CI:6.27-29.04, p:0.0001). Besides, the risk ratio for development of LC was nine times higher in individuals with cancer history in their family than those without cancer history (OR:9.65, 95%CI: 2.79-33.36; p:0.0001). When genotype distributions and allele frequencies were analyzed in the study groups, no significant difference was apparent (χ2:0.53, p=0.76). In addition, no correlation between genotypes of MTHFRC677T polymorphism and histological type of LC was found (χ2:0.99, p=0.60). These results suggest that there was no association between the MTHFR C677T polymorphism and lung cancer in the Turkish population.

20 February 2013 in Bosnian Journal of Basic Medical Sciences
Verified
Journal Article
Open access
PDF file
İSİsmail Sarı
İsmail Sarı
SBSevtap Bakır
Sevtap Bakır
AEAynur Engin
Aynur Engin
HAHüseyin Aydın
Hüseyin Aydın
ÖPÖmer Poyraz
Ömer Poyraz
The purpose of this study is to determine erythrocyte sedimentation rate (ESR), C - reactive protein (CRP), serum amyloid-A (SAA) and cholesterol levels in patients with Crimean-Congo Hemorrhagic Fever (CCHF) and determine the relationship of these parameters with the severity of disease.By polymerase chain reaction and enzyme-linked immunosorbent assay (ELISA) method 40 patients were diagnosed as CCHF and 39 volunteer without any systemic disease whose blood were taken and their serum separated. SAA, CRP and ESR were measured with ELISA, nephelometry and Mix-Rate x100 vital diagnostic device, respectively, in serum samples. High density lipoprotein (HDL), low density lipoprotein (LDL) and total cholesterol levels were determined by using autoanalyzer HDL, LDL and total cholesterol kit (Syncron LX20).Statistically significant difference was determined between patients and controls in terms of the levels of SAA, CRP, HDL, LDL and total cholesterol (p0.05).Using of CRP and SAA together might increase the sensitivity of diagnosis of CCHF infection. However, none of the parameters investigated in this study were found to be a proper marker of the prognosis in CCHF. Cholesterol levels were significantly decreased in patients with CCHF, which was suggested to be associated with the increased serum levels of SAA in the patient group.